VICTR Archives
Wilkins named CTSA co-principal investigator
Jan. 16, 2020—Consuelo Wilkins, MD, MSCI, has joined Gordon Bernard, MD, as co-principal investigator of Vanderbilt’s Clinical and Translational Science Award.
A new anti-seizure target?
Dec. 12, 2019—Vanderbilt neurologists have identified a protein modification that could be targeted to reduce neuronal excitability in epilepsy.
Relational memory in early psychosis
Sep. 10, 2019—Studies of relational memory function may reveal novel mechanisms for therapeutic intervention for patients in the early stages of psychosis.
Working memory in psychotic disorders
Jul. 11, 2019—Functional MRI studies have revealed that targeting activation of certain brain regions may improve working memory and cognition in psychotic disorders.
Clinical study tests drug that may prevent cancer metastasis
Jul. 8, 2019—A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.
Clinic helps adults clarify true status of penicillin allergy
Sep. 27, 2018—by Bill Snyder Two years ago when she was given a type of penicillin to fight off bacterial pneumonia, Kelly Cummins developed a rash, itching and shortness of breath. Suspecting she was having a reaction to the life-saving medication, her doctor stopped the penicillin and substituted a different class of antibiotic. Cummins recovered but now...
VUMC drug repurposing initiative gaining momentum
Apr. 19, 2018—Drug repurposing involves establishing an additional approved indication for a drug already at market.
Grant bolsters study of potential new therapy for C. diff infection
Mar. 22, 2018—According to the Centers for Disease Control and Prevention, in 2011 in the United States there were almost half a million Clostridium difficile infections, and one in 11 patients 65 or older with a healthcare-associated C. diff infection died within 30 days of diagnosis.
Study reveals safety signal from genes that mimic drugs
Mar. 1, 2018—Prospective mothers taking a new class of cholesterol-lowering drugs might incur higher risk of spina bifida in their future children, according to a study published in the journal Drug Safety by researchers at Vanderbilt University Medical Center.
Exhibit translates scientific discoveries into art celebrating Vanderbilt’s Nobel laureates
Oct. 13, 2017—A new exhibit on display at the Wond'ry honors the discoveries of Vanderbilt's Nobel laureates by translating them into beautiful works of art.
New lab formulary improves quality, cuts cost
Sep. 21, 2017—An effort at Vanderbilt University Medical Center (VUMC) to enhance clinical decision making through cross-departmental collaboration and effective use of diagnostics has improved patient care and saved the institution more than $1 million in 2016, VUMC officials reported this week.
Community key to gender identity research effort
Sep. 7, 2017—One of the key elements of the Vanderbilt Program for LGBTI Health, an innovative effort to improve health care for lesbian, gay, bisexual, transgender and intersex patients, is community engagement.
